Fundraising Fox

Magritek

Wellington, NZ · 2 known investors

Magritek develops benchtop NMR spectrometers and related hardware for chemistry laboratories and research applications, enabling on-line monitoring of chemical reactions and analysis. The company serves academic and industrial research institutions requiring high-resolution nuclear magnetic resonance instrumentation.

Advanced ManufacturingDeep TechHardwareNew Materials

Founders & leadership

PS
Professor Sir Paul T. CallaghanFounding Inventor
BB
Bernhard BlümichCo-founder
JPJuan Perlo
Juan PerloinCo-CEO Magritek GmbH
FCFederico Casanova
Federico CasanovainDirector and Group CEO Magritek

Investors · 2

AmpersandBoston
Rangatira InvestmentsAuckland

In the news

Ampersand Invests in Magritek, Leading Supplier of Benchtop NMR Instruments | Ampersand Capital Partnersampersandcapital.com · Mar 2021Rangatira Increases Stake in Magritek | Technology Networkstechnologynetworks.com · Oct 2014Magritek gains Cornerstone Shareholder: Major Institutional Investor Rangatira - Magritekmagritek.com · Jul 2013

Frequently asked questions

What does Magritek do?
Magritek develops benchtop NMR spectrometers and related hardware for chemistry laboratories and research applications, enabling on-line monitoring of chemical reactions and analysis. The company serves academic and industrial research institutions requiring high-resolution nuclear magnetic resonance instrumentation.
Who founded Magritek?
Magritek was founded by Professor Sir Paul T. Callaghan, Bernhard Blümich.
Who are Magritek's investors?
Magritek's investors include Ampersand, Rangatira Investments.
Where is Magritek headquartered?
Magritek is headquartered in Wellington, NZ.